Noradrenaline

Class Vasopressor
Chemistry

Endogenous catecholamine

Routes of administration

IV

Absorption

Basically zero oral availabilty due to destruction by brush border enzymes in the gut (COMT and MAO)

Solubility

pKa = 8.85; water-soluble

Distribution

VOD = 0.12 L/kg, i.e. essentially confined to the circulating volume; 25% protein-bound

Metabolism

Metabolised rapidly and completely by COMT and MAO

Elimination

Metabolites are renally excreted. Half-life is ~2 minutes

Time course of action

Very short acting, very rapid onset of effect

Target receptor

Noradrenaline is highly selective for the alpha-1 receptor

Mechanism of action

By binding to the alpha-1 receptor, noradrenaline increases the release of a secondary messenger (inositol triphosphate, IP3) which results in the release of calcium into the cytosol, and thus enhanced smooth muscle contractility.

Clinical effects

Increased peripheral resistance, increased afterload, increased blood pressure; redistribution of blood flow from splanchnic circulation and skeletal muscle.

Literature reference

TGA PI document

CICM details of understanding Level 1
Mentioned around Deranged Physiology
Related SAQs